Polymorphisms in ERCC2 and overall survival (OS) in early stage non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Suk, R
Park, S
Liu, G
Cogan-Drew, T
Zhou, W
Su, L
Lynch, T
Wain, J
Christiani, D
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：842S / 842S
页数：1
相关论文
共 50 条
  • [41] The value of research for ERCC1 testing in stage I non-small cell lung cancer (NSCLC).
    Roth, J. A.
    Carlson, J. J.
    Steuten, L.
    Ramsey, S. D.
    Veenstra, D. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [42] ERCC2/XPD Polymorphisms and Lung Cancer Risk
    Christiani, David C.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (01) : 233 - 233
  • [43] Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients
    Zhou, Wei
    Heist, Rebecca S.
    Liu, Geoffrey
    Neuberg, Donna S.
    Asomaning, Kofi
    Su, Li
    Wain, John C.
    Lynch, Thomas J.
    Giovannucci, Edward
    Christiani, David C.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (11) : 2239 - 2245
  • [44] POLYMORPHISMS IN THE APOPTOSIS-RELATED GENES AND SURVIVAL OF PATIENTS WITH EARLY STAGE NON-SMALL CELL LUNG CANCER
    Kang, H. G.
    Jeon, H.
    Yoo, S. S.
    Park, J. Y.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S60 - S60
  • [45] The influence of cardiac and pulmonary comorbidities on overall survival (OS) among stage III non-small cell lung cancer (NSCLC) patients treated with definitive radiotherapy (RT)
    Correa, C. R.
    Wang, L.
    Zhao, L.
    Hayman, J.
    Kalemkerian, G.
    Cease, K.
    Brenner, D.
    Kong, F. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S428 - S429
  • [46] Effect of ERCC1 polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patients
    Park, So-Yeon
    Hong, Yun-Chul
    Kim, Jin-Hee
    Kwak, Seung-Min
    Cho, Jae-Hwa
    Lee, Hong-Lyeol
    Ryu, Jeong-Seon
    MEDICAL ONCOLOGY, 2006, 23 (04) : 489 - 498
  • [47] STAGE DISTRIBUTION AT DIAGNOSIS OF NON-SMALL CELL LUNG CANCER (NSCLC) AND GEOGRAPHIC VARIATION IN SURVIVAL
    Chikermane, S.
    Johnson, M. L.
    VALUE IN HEALTH, 2019, 22 : S58 - S58
  • [48] Clinicopathologic Characteristics And Predictors Of Survival In Stage Iv Non-Small Cell Lung Cancer (nsclc)
    Duma, N.
    Listo, M.
    Osorio, C.
    Zhang, S.
    Kang, M.
    Abu-Ihweij, K.
    Harper, H.
    Gutierrez, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [49] Overall Survival Analysis and Characterization of an EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) Population
    Aguiar, Filipa
    Fernandes, Gabriela
    Queiroga, Henrique
    Machado, Jose Carlos
    Cirnes, Luis
    Moura, Conceicao Souto
    Hespanhol, Venceslau
    ARCHIVOS DE BRONCONEUMOLOGIA, 2018, 54 (01): : 10 - 17
  • [50] Relationship between age treatment and overall survival in patients with non-small cell lung cancer (NSCLC)
    Heras, P.
    Hatzopoulos, A.
    Kritikos, K.
    Georgopoulou, A.
    LUNG CANCER, 2007, 55 : S10 - S10
12345